Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use.
J Gastroenterol Hepatol
; 32(12): 1975-1981, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-28295594
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Phenylurea Compounds
/
Bilirubin
/
Niacinamide
/
Carcinoma, Hepatocellular
/
Albuminuria
/
Liver Function Tests
/
Liver Neoplasms
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
J Gastroenterol Hepatol
Year:
2017
Type:
Article
Affiliation country:
Taiwan